Cann Group Limited

Equities

CAN

AU000000CAN2

Healthcare Facilities & Services

Market Closed - Australian S.E. 12:10:47 2024-02-29 am EST 5-day change 1st Jan Change
0.062 AUD -1.59% Intraday chart for Cann Group Limited -.--% -36.08%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cann Group Secures Final Payment for Sale of Southern Facility MT
Cann Group CEO Resigns MT
Jenni Pilcher to Become Executive Director of Cann Group Limited CI
Cann Group Limited Announces the Resignation of Peter Koetsier as Chief Executive Officer CI
Cann Group Executes AU$1.7 Million Sale and Purchase Agreement, Extends Funding Facility MT
Cann Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Cann Group to Defend Business Against Rua Bioscience Claims As Dispute Goes Legal MT
Rua Initiates Legal Action Against Cannoperations MT
Atlas Pearls CFO Resigns; Shares Rise 3% MT
Cann Group Appoints New Chief Financial Officer MT
Cann Group Limited Announces Chief Financial Officer Changes, Commencing on 8 April 2024 CI
Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs CI
Cann Group Limited Announces Resignation of Deborah Ambrosini as Chief Financial Officer, Effective December 22, 2023 CI
Cann Group Limited Announces Change of Company Secretary CI
Rua Bioscience Announces Changes to the Supply Agreement with Cann Group CI
Cann Group Raises AU$2 Million From Obsidian MT
How Huawei plans to rival Nvidia in the AI chip business RE
Heritage Cannabis Begins Recreational Products Sales in New York MT
US chip curbs give Huawei a chance to fill the Nvidia void in China RE
Cann Group to Supply Additional Cannabis Flower, Oil Products to Levin MT
Cann Group Limited Signs Variation Agreement with Key Customer for Additional Supply of Cannabis Flower Products to 31 December 2023 CI
Cann Global Seeks Further Trading Suspension MT
Transcript : Cann Group Limited, 2023 Earnings Call, Aug 28, 2023
Cann Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Cann Group Closes AU$11.7 Million Rights Offer; Shares Rise 8% MT
Chart Cann Group Limited
More charts
Cann Group Limited is an Australia-based company that is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.
More about the company

Annual profits - Rate of surprise